Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO and SUZHOU, China, April 24, 2024 SAN FRANCISCO and SUZHOU, China , April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases,...